International Journal of Nephrology最新文献

{"title":"Urinary Tract Infections in the First 6 Months after Renal Transplantation.","authors":"Ziad Arabi,&nbsp;Khalefa Al Thiab,&nbsp;Abdulrahman Altheaby,&nbsp;Ghaleb Aboalsamh,&nbsp;Samy Kashkoush,&nbsp;Mohamad Almarastani,&nbsp;Mohammed F Shaheen,&nbsp;Abdulrahman Altamimi,&nbsp;Wael O'hali,&nbsp;Khalid Bin Saad,&nbsp;Lina Alnajjar,&nbsp;Rawan Alhussein,&nbsp;Raghad Almuhiteb,&nbsp;Bashayr Alqahtani,&nbsp;Rayana Alotaibi,&nbsp;Marah Alqahtani,&nbsp;Mohammed Tawhari","doi":"10.1155/2021/3033276","DOIUrl":"https://doi.org/10.1155/2021/3033276","url":null,"abstract":"<p><strong>Purpose: </strong>Urinary tract infections (UTIs) are common in the first 6 months after renal transplantation, and there are only limited data about UTIs after transplantation in Saudi Arabia in general.</p><p><strong>Methods: </strong>A retrospective study from January 2017 to May 2020 with 6-month follow-up.</p><p><strong>Results: </strong>279 renal transplant recipients were included. Mean age was 43.4 ± 16.0 years, and114 (40.9%) were women. Urinary stents were inserted routinely during transplantation and were removed 35.3 ± 28 days postoperatively. Ninety-seven patients (35%) developed urinary tract infections (UTIs) in the first six months after renal transplantation. Of those who developed the first episode of UTI, the recurrence rates were 57%, 27%, and 14% for having one, two, or three recurrences, respectively. Late urinary stent removals, defined as more than 21 days postoperatively, tended to have more UTIs (OR: 1.43, P: 0.259, CI: 0.76-2.66). Age >40, female gender, history of neurogenic bladder, and transplantation abroad were statistically significant factors associated with UTIs and recurrence. Diabetes, level of immunosuppression, deceased donor renal transplantation, pretransplant residual urine volume, or history of vesicoureteral reflux (VUR) was not associated with a higher incidence of UTIs. UTIs were asymptomatic in 60% but complicated with bacteremia in 6% of the cases. Multidrug resistant organisms (MDROs) were the causative organisms in 42% of cases, and in-hospital treatment was required in about 50% of cases. Norfloxacin + Bactrim DD (160/800 mg) every other day was not associated with the lower risk of developing UTIs compared to the standard prophylaxis daily Bactrim SS (80/400 mg).</p><p><strong>Conclusion: </strong>UTIs and recurrence are common in the first 6 months after renal transplantation. Age >40, female gender, neurogenic bladder, and transplantation abroad are associated with the increased risk of UTIs and recurrence. MDROs are common causative organisms, and hospitalization is frequently required. Dual prophylactic antibiotics did not seem to be advantageous over the standard daily Bactrim.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"3033276"},"PeriodicalIF":2.1,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39909447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and Risk Factors Associated with Hepatitis B and Hepatitis C Infections among Patients Undergoing Hemodialysis: A Single-Centre Study in Somalia.","authors":"Mohamed Osman Omar Jeele,&nbsp;Rukia Omar Barei Addow,&nbsp;Faduma Nur Adan,&nbsp;Liban Hassan Jimale","doi":"10.1155/2021/1555775","DOIUrl":"https://doi.org/10.1155/2021/1555775","url":null,"abstract":"<p><strong>Introduction: </strong>Hemodialysis patients have the highest risk for developing hepatitis B virus (HBV) and hepatitis C virus (HCV) than the general population. There is no study available for HBV and HCV in this population in Somalia. The main objective of this study is to determine the prevalence and risk factors of HBV and HCV infections among hemodialysis patients in Somalia.</p><p><strong>Methods: </strong>A cross-sectional assessment of hemodialysis patients from January 2021 to June 2021 was used in this study. 220 patients were included in this study. Age, sex, duration of hemodialysis, number of hemodialysis sessions per week, history of blood transfusion, HbsAg, and anti-HCV antibodies were examined.</p><p><strong>Results: </strong>Out of the 220 patients, males were predominant (113 (51.4%)). The mean age of the participants was 52.70. The prevalence of HBV was 7.3% (16 respondents), while the prevalence of HCV was 3.2% (7 respondents). 1 respondent (0.5%) had both HBV and HCV. There is a positive correlation between the duration of hemodialysis and the prevalence of HBV and HCV (<i>r</i>(218) = 0.298, <i>p</i> value <0.001), blood transfusion and prevalence of HBV and HCV (<i>r</i>(218) = 0.347, <i>p</i> value <0.001), and the number of hemodialysis sessions per week and prevalence of HBV and HCV (<i>r</i>(218) = 0.402, <i>p</i> value <0.001). The regression model of the combined predictors of history of blood transfusion, duration of hemodialysis, and number of dialysis sessions per week is <i>R</i> ² = 0.25, which indicates a 25% variance in the prevalence of HBV and HCV with a significance of <i>F</i> (3,216) = 23.67, <i>p</i> < 0.001.</p><p><strong>Conclusions: </strong>The prevalence of HBV and HCV among hemodialysis patients in this study was 7.3% and 3.2%, respectively. 0.5% of the respondents had both HBV and HCV. History of blood transfusion, duration of hemodialysis, and number of hemodialysis sessions per week appear to have a strong correlation with the prevalence of HBV and HCV.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"1555775"},"PeriodicalIF":2.1,"publicationDate":"2021-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39761885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SARS-CoV-2 Infection in Kidney Transplant Recipients: A Single-Centre Study of 20 Cases from India.","authors":"Ravi Raju Tatapudi,&nbsp;Venkateswara Rao Kopparti,&nbsp;Anusha Poosapati,&nbsp;Srinivas Metta,&nbsp;Atchyutha Rao Gongada,&nbsp;Balakrishna Vedulla","doi":"10.1155/2021/2243095","DOIUrl":"https://doi.org/10.1155/2021/2243095","url":null,"abstract":"<p><strong>Introduction: </strong>The second wave of COVID-19 has spread across India causing unprecedented misery to people since March 2021. Kidney transplant recipients (KTRs) are at an increased risk of severe infection. Their outcomes appear to be worse than those in the general population. There is no robust evidence or consensus to support any form of treatment protocol or modification of immunosuppression in KTRs with COVID-19. There is a need to develop effective and safe therapeutic protocols for this frail population. Remdesivir is the only approved antiviral drug in COVID-19 till now.</p><p><strong>Methods: </strong>We describe clinical features, role of HRCT, therapeutic protocols, and mortality rate of 20 KTRs with SARS-CoV-2 infection.</p><p><strong>Results: </strong>Complete recovery was seen in 8 (40%) patients monitored at home. 12 (60%) patients with HRCT scores more than 8/25 were hospitalized. 11 (55%) had hypoxia, of these 8 (40%) had mild hypoxia, 1 (5%) required NIV, and 2 (10%) needed mechanical ventilation. Immunosuppression was modified in all the patients. Remdesivir and dexamethasone were administered to the hospitalized patients. 1 (5%) patient had AKI requiring RRT. 1 (5%) patient expired, and 1 still hospitalized. 10 of the hospitalized patients recovered. Out of the total 20 patients, 18 (90%) recovered completely within two weeks of infection.</p><p><strong>Conclusion: </strong>Clinical presentation of COVID-19 in KTRs was similar to nontransplant patients. Early hospitalisation and assessing the severity by HRCT were important. Continuing tacrolimus and administering remdesivir and dexamethasone reduced the incidence of renal failure and improved survival rates.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"2243095"},"PeriodicalIF":2.1,"publicationDate":"2021-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39597981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities.","authors":"Yin Li,&nbsp;Zixin Sha,&nbsp;Hui Peng","doi":"10.1155/2021/5497346","DOIUrl":"https://doi.org/10.1155/2021/5497346","url":null,"abstract":"<p><p>Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after kidney injury, and these cells undergo different kinds of metabolic reprogramming in different kidney diseases. Metabolic reprogramming also plays a role in the progression and prognosis of kidney diseases. Therefore, metabolic reprogramming is not only a prominent feature but also an important contributor to the pathophysiology of kidney diseases. Here, we briefly review kidney diseases and metabolic reprogramming and discuss new ways to treat kidney diseases.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"5497346"},"PeriodicalIF":2.1,"publicationDate":"2021-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560294/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39855412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Renoprotective Effects of Our Locally Grown Green Coffee Beans against Cisplatin-Induced Nephrotoxicity in Swiss Albino Mice.","authors":"Bati Leta,&nbsp;Chala Kenenisa,&nbsp;Tesaka Wondimnew,&nbsp;Tariku Sime","doi":"10.1155/2021/2805068","DOIUrl":"10.1155/2021/2805068","url":null,"abstract":"<p><strong>Introduction: </strong>Nephrotoxicity is the most common and severe side effect of cisplatin. Cisplatin causes nephrotoxicity through free radical production and debilitating cellular antioxidant capacity. Coffee is a commonly consumed drink and its ingredients have antioxidant roles that could bring benefits to patients affected by nephrotoxicity. Thus, the present study aimed to investigate the renoprotective effects of our locally grown green coffee beans against cisplatin-induced nephrotoxicity in Swiss albino mice.</p><p><strong>Methods: </strong>The posttest only control group design was employed on a total of thirty male Swiss albino mice. The mice were divided into five groups: group I (normal control group) received distilled water; group II (negative control group) received distilled water; and groups III-V (treatment groups) received 100, 200, and 300 mg/kg BW/day of green coffee bean extract for 14 days, respectively. Nephrotoxicity was induced in groups II-V by a single intraperitoneal injection of cisplatin (7.5 mg/kg). All mice were sacrificed after 14 days and blood was drawn to evaluate kidney function tests (serum creatinine and serum blood urea nitrogen). Besides, body weight, relative kidney weight, and kidney histopathology were investigated.</p><p><strong>Result: </strong>Our results showed that treatment of cisplatin alone (group II mice) significantly increased serum creatinine, serum blood urea nitrogen, relative kidney weight, and pathological damage to the kidney with a decrease in final body weight. However, low-dose green coffee beans (group III), medium-dose green coffee beans (group IV), and high-dose green coffee beans (group V) mice showed a significant dose-dependent decrease in serum creatinine, serum blood urea nitrogen, and relative kidney weight. Furthermore, the dose-dependent treatment with green coffee bean extract prevented the decrease in body weight gain and pathological damage to the kidney in mice.</p><p><strong>Conclusion: </strong>Our locally grown green coffee beans brought a dose-dependent ameliorative effect and a promising preventive approach against cisplatin-induced kidney damage in mice.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"2805068"},"PeriodicalIF":2.1,"publicationDate":"2021-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39539009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Human Leukocyte Antigen Class I and Class II in End-Stage Renal Disease Occurrence in Indonesian Transplantation Patients.","authors":"Hani Susianti,&nbsp;Dwi Priyadi Djatmiko,&nbsp;I Komang Adi Widana,&nbsp;Deasy Ayuningtyas Tandio,&nbsp;Catur Suci Sutrisnani,&nbsp;Singgih Pudjo Wahono,&nbsp;Ira Puspitawati","doi":"10.1155/2021/4219822","DOIUrl":"https://doi.org/10.1155/2021/4219822","url":null,"abstract":"<p><strong>Background: </strong>Genetic studies of end-stage renal disease (ESRD), including those of human leukocyte antigen (HLA) genes, have been reported in several populations but have not yet been evaluated in Indonesia. Some studies have reported that these genes had a substantial role in ESRD. This study aims to analyze the association between HLA genes and ESRD within the Indonesian community.</p><p><strong>Method: </strong>A retrospective study to investigate HLA class I and II alleles to find out the distribution of HLA-A, -B, -C, -DPB1, -DQB1, and -DRB1 in renal transplant recipients and to ascertain their role in susceptibility to ESRD was performed on totally 149 subjects, consisting of 69 ESRD patients and 80 healthy controls. HLA typing was determined using Luminex techniques. The allele and haplotype frequencies were compared between ESRD patients and controls.</p><p><strong>Result: </strong>High-frequency alleles were HLA-A<i>∗</i>24 (43.6%), B<i>∗</i>15 (38.2%), C<i>∗</i>08 (30.8%), DRB1<i>∗</i>12 (47.3%), DQB1<i>∗</i>03 (50.6%), and DPB1<i>∗</i>13 (22.5%). HLA-A<i>∗</i>24 (<i>p</i>=0.01) and HLA-B<i>∗</i>35 (<i>p</i>=0.02) were associated with a protective effect, with OR 0.537 (95%CI 0.34-0.86) and 0.316 (95%CI 0.11-0.88), respectively. There were some two-locus haplotypes associated with susceptibility to ESRD, such as B<i>∗</i>15-DRB1<i>∗</i>12, B<i>∗</i>13-DRB1<i>∗</i>15, A<i>∗</i>02-B<i>∗</i>15, A<i>∗</i>02-C<i>∗</i>08, and B<i>∗</i>13-DQB1<i>∗</i>05. HLA-A<i>∗</i>02-B<i>∗</i>15-DRB1<i>∗</i>12 and A<i>∗</i>24-B<i>∗</i>13-DRB1<i>∗</i>15 appear to be associated with susceptibility to ESRD.</p><p><strong>Conclusion: </strong>The allele groups of HLA-A<i>∗</i>24 and HLA-B<i>∗</i>35 are associated with protection from ESRD. Meanwhile, HLA-B<i>∗</i>13-DRB1<i>∗</i>15 and A<i>∗</i>24-B<i>∗</i>13-DRB1<i>∗</i>15 are the most frequent HLAs associated with ESRD in two-locus and three-locus haplotype, respectively.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"4219822"},"PeriodicalIF":2.1,"publicationDate":"2021-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39538278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"COVID-19 Infection Clinical Profile, Management, Outcome, and Antibody Response in Kidney Transplant Recipients: A Single Centre Experience.","authors":"Sanjiv Jasuja, Gaurav Sagar, Anupam Bahl, Shalini Verma","doi":"10.1155/2021/3129411","DOIUrl":"10.1155/2021/3129411","url":null,"abstract":"<p><strong>Introduction: </strong>Experience of COVID-19 in kidney transplant recipients (KTRs) with clinical presentation, management, factors influencing mortality, and antibody response is limited. <i>Material and Methods</i>. A retrospective data of COVID-19 in KTRs was collected and analyzed. The mortality rate, risk factors, and antibody response were primary objectives, while the clinical presentation, laboratory indicators, and pharmacological management were secondary objectives.</p><p><strong>Results: </strong>The 67 KTRs with polymerase chain reaction (PCR) confirmed COVID-19 infection reported between 1 May 2020 and 31 December 2020; 61.2% of patients were hospitalized; and 20.9% needed ventilation. The overall mortality was 26.9%, while blood group A had 50% mortality. The treatment options and used were steroids (100%), convalescent plasma (32.8%), ivermectin (58.2%), doxycycline (55.2%), remdesivir (34.3%), tocilizumab (10.4%), antibiotics (61.2%), anti-fungals (26.9%), low molecular weight heparin (45.3%), and oral anti-coagulants (26.9%). Anti-nucleosides (mycophenolate or azathioprine) were discontinued in 76.1% and calcineurin inhibitors (CNI) in 26.9%. Significant mortality (<i>p</i> < 0.001) was observed in patients presenting with SpO₂ <94 needing ICU care, ventilation, dialysis/acute kidney injury (AKI), and empirical therapies like convalescent plasma and remdesivir. The age of survivors versus nonsurvivors was not significantly different (<i>p</i>=0.02). The positive blood culture, low serum albumin, high TLC, high blood urea, interleukin-6, and CT severity score ≥15 were statistically significant in nonsurvivors. Overall mortality, mortality of hospitalized patients, and mortality of ventilated patients was 27%, 44%, and 100%, respectively. The median value of SARS-CoV-2 (COVID-19) IgG antibody was 68.60 (IQR, 28.5-94.25) AU/ml in more than 90% of survivors.</p><p><strong>Conclusion: </strong>KTRs with COVID-19, needing ICU care, dialysis and ventilation support had poor outcomes. Recovered patients mounted adequate antibody response.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"3129411"},"PeriodicalIF":2.1,"publicationDate":"2021-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39491945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Relation of Wnt Signaling Pathway Inhibitors (Sclerostin and Dickkopf-1) to Left Ventricular Mass Index in Maintenance Hemodialysis Patients.","authors":"Ahmed Bahie,&nbsp;Mohamed M Abdalbary,&nbsp;Dalia Younis El-Sayed,&nbsp;Rasha Elzehery,&nbsp;Ghada El-Said,&nbsp;Ghada El-Kannishy,&nbsp;Ahmed M Abd El Wahab","doi":"10.1155/2021/2439868","DOIUrl":"10.1155/2021/2439868","url":null,"abstract":"<p><strong>Background: </strong>Left ventricular hypertrophy (LVH) is common in hemodialysis (HD) patients. It predicts poor prognosis. Several inhibitors regulate Wnt canonical pathways like Dickkopf-related protein-1 (Dkk-1) and sclerostin.</p><p><strong>Objectives: </strong>To investigate the relationship between serum sclerostin, Dkk-1, left ventricular mass (LVM), and LVM index (LVMI) in HD patients.</p><p><strong>Methods: </strong>This is a cross-sectional study including 65 HD patients in our HD unit. Patients were divided into two groups according to LVMI (group 1 with LVMI < 125 gm/m² (<i>N</i> = 29) and group 2 with LVMI > 125 gm/m² (<i>N</i> = 36)). Echocardiographic evaluation of the LVM, aortic, and mitral valves calcification (AVC and MVC) was done. Serum levels of sclerostin and Dkk-1 and patients' clinical and biochemical data were recorded.</p><p><strong>Results: </strong>Group 2 showed significantly higher age, blood pressure, AVC, and MVC and significantly lower hemoglobin, sclerostin, and Dkk-1 levels. LVM and LVMI had a significant linear negative correlation to both serum sclerostin and Dkk-1 (<i>r</i> = -0.329 and -0.257, <i>P</i>=0.01 and 0.046 for LVM; <i>r</i> = -0.427 and -0.324, <i>P</i>=0.001 and 0.012 for LVMI, resp.). Serum Dkk-1 was an independent negative indicator for LVM and LVMI in multiple regression analyses (<i>P</i>=0.003 and 0.041 with 95% CI = -0.963 to -0.204 and -0.478 to -0.010, resp.).</p><p><strong>Conclusion: </strong>Serum sclerostin and Dkk-1 were significantly lower in HD patients with increased LVMI > 125 gm/m², and both had a significant linear negative correlation with LVM and LVMI. Dkk-1 was a significant negative independent indicator for LVM and LVMI in HD patients.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"2439868"},"PeriodicalIF":2.1,"publicationDate":"2021-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39483682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Total Body Sodium Balance in Chronic Kidney Disease.","authors":"Kylie Martin,&nbsp;Sven-Jean Tan,&nbsp;Nigel D Toussaint","doi":"10.1155/2021/7562357","DOIUrl":"https://doi.org/10.1155/2021/7562357","url":null,"abstract":"<p><p>Excess sodium intake is a leading but modifiable risk factor for mortality, with implications on hypertension, inflammation, cardiovascular disease, and chronic kidney disease (CKD). This review will focus mainly on the limitations of current measurement methods of sodium balance particularly in patients with CKD who have complex sodium physiology. The suboptimal accuracy of sodium intake and excretion measurement is seemingly more marked with the evolving understanding of tissue (skin and muscle) sodium. Tissue sodium represents an extrarenal influence on sodium homeostasis with demonstrated clinical associations of hypertension and inflammation. Measurement of tissue sodium has been largely unexplored in patients with CKD. Development and adoption of more comprehensive and dynamic assessment of body sodium balance is needed to better understand sodium physiology in the human body and explore therapeutic strategies to improve the clinical outcomes in the CKD population.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"7562357"},"PeriodicalIF":2.1,"publicationDate":"2021-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481067/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39483683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and Validation of Creatinine-Based Estimates of the Glomerular Filtration Rate Equation from ^99mTc-DTPA Imaging in the Malaysian Setting.","authors":"Azrina Md Ralib,&nbsp;Farah Nadia Mohd Hanafiah,&nbsp;Iqbalmunawwir Abd Rashid,&nbsp;Mohamad Shahrir Abd Rahim,&nbsp;Fatimah Dzaharudin,&nbsp;Mohd Basri Mat Nor","doi":"10.1155/2021/3465472","DOIUrl":"https://doi.org/10.1155/2021/3465472","url":null,"abstract":"<p><strong>Introduction: </strong>Accurate assessment of glomerular filtration rate (GFR) is very important for diagnostic and therapeutic intervention. Clinically, GFR is estimated from plasma creatinine using equations such as Cockcroft-Gault, Modification of Diet in Renal Disease, and Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equations. However, these were developed in the Western population. To the best of our knowledge, there was no equation that has been developed specifically in our population.</p><p><strong>Objectives: </strong>We developed a new equation based on the gold standard of ^99mTc-DTPA imaging measured GFR. We then performed an internal validation by comparing the bias, precision, and accuracy of the new equation and the other equations with the gold standard of ^99mTc-DTPA imaging measured GFR.</p><p><strong>Methods: </strong>This was a cross-sectional study using the existing record of patients who were referred for ^99mTc-DTPA imaging at the Nuclear Medicine Centre, International Islamic University Malaysia. As this is a retrospective study utilising routinely collected data from the existing pool of data, the ethical committee has waived the need for informed consent.</p><p><strong>Results: </strong>Data of 187 patients were analysed from January 2016 to March 2021. Of these, 94 were randomised to the development cohort and 93 to the validation cohort. A new equation of eGFR was determined as 16.637 ∗ 0.9935^Age ∗ (SCr/23.473)^-0.45159. In the validation cohort, both CKD-EPI and the new equation had the highest correlation to ^99mTc-DTPA with a correlation coefficient of 0.81 (<i>p</i> < 0.0001). However, the new equation had the least bias and was the most precise (mean bias of -3.58 ± 12.01) and accurate (P30 of 64.5% and P50 of 84.9%) compared to the other equations.</p><p><strong>Conclusion: </strong>The new equation which was developed specifically using our local data population was the most accurate and precise, with less bias compared to the other equations. Further study validating this equation in the perioperative and intensive care patients is needed.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2021 ","pages":"3465472"},"PeriodicalIF":2.1,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39430531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}